Evidence map›Paper›PMID 40808374›Full record

ArticleMycoses2025

Global Emergence of Antifungal-Resistant Dermatophytosis Caused by Trichophyton indotineae (Formerly T. mentagrophytes ITS Genotype VIII): A Genomic Investigation Involving 14 Countries.

Amanda Ribeiro Dos Santos, Silke Uhrlaß, Pietro Nenoff, Jeremy A W Gold, Mohammed Saiful Islam Bhuiyan, Srikumar Goturu, Lalitha Gade, Ujwal R Bagal, Joyce G Peterson, Nathan P Wiederhold and 12 more

Abstract read
In one paragraph

Article in Mycoses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Dermatophytosis: An Update on Global Epidemiology.Journal of fungi (Basel, Switzerland) · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. The emergence of superficial dermatophytosis due toJournal of clinical microbiology · 2026
    Article
  10. The entireAntimicrobial agents and chemotherapy · 2026
    Article
  11. Article
  12. Article
  13. Global Emergence ofInfection and drug resistance · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Amanda Ribeiro Dos SantosMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-5577-4498
Silke UhrlaßLabopart-Medical Laboratories, Roetha OT Moelbis, Germany.
Pietro NenoffLabopart-Medical Laboratories, Roetha OT Moelbis, Germany.
Jeremy A W GoldMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-5054-7616
Mohammed Saiful Islam BhuiyanBangabandhu Sheikh Mujib Medical University, Paribagh, Bangladesh.
Srikumar GoturuDr Joseph's Polyclinic (Amber), Dubai, UAE.
Lalitha GadeMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Ujwal R BagalMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Joyce G PetersonMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Nathan P WiederholdDepartment of Pathology and Laboratory Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.ORCID https://orcid.org/0000-0002-2225-5122
Shawn R LockhartMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-4383-5994
Helle JärvSYNLAB Eesti OÜ, Tallinn, Estonia.ORCID https://orcid.org/0000-0001-6574-7365
Ammar F HameedDermatology Office Schongau, Schongau, Germany.
Jacek SzepietowskiWroclaw University of Science and Technology, Wroclaw, Poland.
Resham VasaniBhojani Clinic, Mumbai, India.
Archana SingalUniversity College of Medical Sciences and GTB Hospital, Delhi, India.ORCID https://orcid.org/0000-0001-9201-3391
Lindsay ParnellMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Brian SchwemMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Tom ChillerMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Anastasia P LitvintsevaMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Nancy A ChowMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Shyam B VermaNirvan and in Skin Clinics, Vadodara, Gujarat, India.ORCID https://orcid.org/0000-0003-1959-0517

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

BACKGROUND AND

objectiveTrichophyton indotineae is a globally emerging, frequently antifungal-resistant fungus causing severe dermatophytosis. To inform prevention efforts, we analysed the genomic epidemiology and resistance to terbinafine (first-line oral antifungal) from a collection of multinational T. indotineae isolates collected from patients with clinically suspected dermatophytosis during 2016-2023.

methodsWe performed whole genome sequencing and phylogenetic tree analysis based on single-nucleotide polymorphisms (SNPs). T. indotineae phylogenetic results were correlated with patient demographic characteristics and isolate terbinafine susceptibility profiles that were determined by antifungal susceptibility testing and squalene epoxidase gene sequencing. Trichophyton mentagrophytes and Trichophyton interdigitale isolates from the USA, and Trichophyton rubrum isolates from three countries were added for contextual analysis.

resultsAmong 347 T. indotineae isolates, 227 (65%) were in vitro resistant to terbinafine. Countries represented were India (43%); Germany (21%); Bangladesh (8%); United States (8%); United Arab Emirates (7%); Iraq (5%); Finland (3%); Poland (2%); Austria, Canada, Cambodia, Estonia, Singapore, and Switzerland (each < 1%). Median SNP difference between isolates was 106 SNPs (range: 0-392). Clustering by age, sex, or country was not observed. One subcluster was composed of terbinafine-resistant isolates with a specific squalene epoxidase gene mutation (F397L) and was widely dispersed among 10 countries. Intra-species genomic diversity was greater among 19 T. rubrum isolates (260 SNPs [range: 73-1038]), or among 10 T. mentagrophytes/T. interdigitale isolates from the USA compared with the intra-species diversity of the T. indotineae isolates.

conclusionsOur findings corroborate T. indotineae's recent emergence and ongoing international transmission and suggest the rapid spread of a subset of terbinafine-resistant isolates. Continued efforts are necessary to mitigate this pathogen's spread.

Indexed as

Antifungal AgentsDrug Resistance, FungalTineaTrichophytonAdolescentAdultAgedArthrodermataceaeChildChild, PreschoolFemaleGenotypeGlobal HealthHumansMaleMicrobial Sensitivity TestsAntifungal AgentsSqualene MonooxygenaseTerbinafinedermatophytosisgenomic epidemiologymultinational studyphylogenetic analysissqualene epoxidaseterbinafineTrichophyton indotineaeantifungal resistance

Identifiers

PMID40808374
PMCPMC12393040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.